MX368972B - Composiciones de glicoproteínas sialiladas y usos de estas. - Google Patents
Composiciones de glicoproteínas sialiladas y usos de estas.Info
- Publication number
- MX368972B MX368972B MX2016011416A MX2016011416A MX368972B MX 368972 B MX368972 B MX 368972B MX 2016011416 A MX2016011416 A MX 2016011416A MX 2016011416 A MX2016011416 A MX 2016011416A MX 368972 B MX368972 B MX 368972B
- Authority
- MX
- Mexico
- Prior art keywords
- glycoprotein compositions
- sialylated glycoprotein
- sialylated
- compositions
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461948421P | 2014-03-05 | 2014-03-05 | |
| US201562114313P | 2015-02-10 | 2015-02-10 | |
| PCT/US2015/018859 WO2015134696A1 (en) | 2014-03-05 | 2015-03-05 | Sialylated glycoprotein compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016011416A MX2016011416A (es) | 2016-12-02 |
| MX368972B true MX368972B (es) | 2019-10-23 |
Family
ID=54016314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016011416A MX368972B (es) | 2014-03-05 | 2015-03-05 | Composiciones de glicoproteínas sialiladas y usos de estas. |
Country Status (17)
| Country | Link |
|---|---|
| US (9) | US9457067B2 (enExample) |
| EP (1) | EP3113781B1 (enExample) |
| JP (1) | JP6581590B2 (enExample) |
| KR (1) | KR102150481B1 (enExample) |
| CN (1) | CN106102749B (enExample) |
| AU (1) | AU2015227137B2 (enExample) |
| BR (1) | BR112016019893B1 (enExample) |
| CA (1) | CA2940318C (enExample) |
| ES (1) | ES2704923T3 (enExample) |
| IL (1) | IL247550B (enExample) |
| MX (1) | MX368972B (enExample) |
| MY (1) | MY188028A (enExample) |
| PE (1) | PE20161417A1 (enExample) |
| PH (1) | PH12016501658A1 (enExample) |
| RU (1) | RU2689119C2 (enExample) |
| TW (1) | TWI702049B (enExample) |
| WO (1) | WO2015134696A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX368972B (es) | 2014-03-05 | 2019-10-23 | Ultragenyx Pharmaceutical Inc | Composiciones de glicoproteínas sialiladas y usos de estas. |
| EP3724314A1 (en) | 2017-12-13 | 2020-10-21 | 3M Innovative Properties Company | Water-reconstitutable culture medium resistant to liquefaction by microorganisms |
| TWI667252B (zh) * | 2018-07-13 | 2019-08-01 | 中原大學 | 阿伐-選擇性唾液酸供體及其於製備唾液酸苷的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458574B1 (en) | 1996-09-12 | 2002-10-01 | Transkaryotic Therapies, Inc. | Treatment of a α-galactosidase a deficiency |
| CA2492267C (en) * | 2002-07-15 | 2013-09-10 | Immunex Corporation | Methods and media for controlling sialylation of proteins produced by mammalian cells |
| US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| EP1699821B1 (en) * | 2003-12-31 | 2012-06-20 | Merck Patent GmbH | Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS |
| EP1818395A1 (en) * | 2006-02-08 | 2007-08-15 | Diatos | Compositions and methods for treating lysosomal storage diseases |
| WO2008028686A2 (en) * | 2006-09-10 | 2008-03-13 | Glycotope Gmbh | Use of human cells of myeloid leukaemia origin for expression of antibodies |
| WO2008109677A2 (en) * | 2007-03-06 | 2008-09-12 | Saint Louis University | Modified enzyme and treatment method |
| WO2011096750A2 (en) * | 2010-02-08 | 2011-08-11 | Korea Advanced Institute Of Science And Technology | Method for preparing recombinant glycoproteins with high sialic acid content |
| WO2012101671A1 (en) * | 2011-01-25 | 2012-08-02 | Jcr Pharmaceuticals Co., Ltd. | Method for production of human recombinant iduronate 2-sulfatase |
| KR101457514B1 (ko) * | 2011-11-21 | 2014-11-03 | 한국생명공학연구원 | 우렁쉥이(멍게) 유래의 시알산 전이효소 및 이를 이용한 시알화 복합당질 합성 방법 |
| US10138474B2 (en) * | 2012-08-17 | 2018-11-27 | Research Foundation Of The City University Of New York | Scavenger receptor uptake for fabry disease enzyme replacement therapy |
| MX368972B (es) | 2014-03-05 | 2019-10-23 | Ultragenyx Pharmaceutical Inc | Composiciones de glicoproteínas sialiladas y usos de estas. |
-
2015
- 2015-03-05 MX MX2016011416A patent/MX368972B/es active IP Right Grant
- 2015-03-05 BR BR112016019893-0A patent/BR112016019893B1/pt active IP Right Grant
- 2015-03-05 KR KR1020167026994A patent/KR102150481B1/ko active Active
- 2015-03-05 MY MYPI2016001608A patent/MY188028A/en unknown
- 2015-03-05 PE PE2016001535A patent/PE20161417A1/es not_active Application Discontinuation
- 2015-03-05 AU AU2015227137A patent/AU2015227137B2/en active Active
- 2015-03-05 WO PCT/US2015/018859 patent/WO2015134696A1/en not_active Ceased
- 2015-03-05 EP EP15758766.8A patent/EP3113781B1/en active Active
- 2015-03-05 JP JP2016553591A patent/JP6581590B2/ja active Active
- 2015-03-05 CA CA2940318A patent/CA2940318C/en active Active
- 2015-03-05 TW TW104107083A patent/TWI702049B/zh active
- 2015-03-05 RU RU2016138790A patent/RU2689119C2/ru active
- 2015-03-05 CN CN201580015886.XA patent/CN106102749B/zh active Active
- 2015-03-05 ES ES15758766T patent/ES2704923T3/es active Active
- 2015-03-05 US US14/639,171 patent/US9457067B2/en active Active
- 2015-09-10 US US14/849,745 patent/US9457068B2/en active Active
-
2016
- 2016-08-19 PH PH12016501658A patent/PH12016501658A1/en unknown
- 2016-08-30 US US15/251,701 patent/US9687532B2/en active Active
- 2016-08-30 IL IL247550A patent/IL247550B/en active IP Right Grant
-
2017
- 2017-05-26 US US15/607,257 patent/US9937243B2/en active Active
-
2018
- 2018-04-02 US US15/943,526 patent/US20190054153A1/en not_active Abandoned
-
2020
- 2020-01-09 US US16/738,938 patent/US20200282028A1/en not_active Abandoned
-
2021
- 2021-11-11 US US17/524,628 patent/US20220202915A1/en not_active Abandoned
-
2023
- 2023-12-07 US US18/532,665 patent/US20240245759A1/en not_active Abandoned
-
2025
- 2025-07-17 US US19/272,719 patent/US20260077025A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| PL3145522T3 (pl) | Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom | |
| MX385845B (es) | Usos y composiciones de la flagelina | |
| MX360041B (es) | Composiciones y metodos para el cuidado personal. | |
| MX395231B (es) | Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos. | |
| BR112016017112A2 (pt) | Composições de apilimod e métodos de uso das mesmas | |
| PH12017500836A1 (en) | Transdermal formulations | |
| EA201790461A1 (ru) | Композиции внеклеточного матрикса | |
| MX374385B (es) | Apilimod para uso en el tratamiento de melanoma. | |
| MX386055B (es) | Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson. | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| MX2023010501A (es) | Profarmacos de dantroleno y metodos de su uso. | |
| MX390126B (es) | Nuevas isoformas de tripsina y su uso. | |
| MX379126B (es) | Formulación de factor viii. | |
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| IT201600130012A1 (it) | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale | |
| MX2016011416A (es) | Composiciones de glicoproteinas sialiladas y usos de estas. | |
| MX378868B (es) | Sintesis de polioles polimericos en polioles insaturados, polioles polimericos y su uso. | |
| ECSP18050673A (es) | Formulaciones de giberelina en solución concentrada | |
| MX383460B (es) | Derivados peptidicos novedosos y sus usos. | |
| MX385652B (es) | Composicion heterofasica. | |
| MX380683B (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina. | |
| MY171137A (en) | Thioguanine derivatives | |
| DOP2015000290A (es) | Benzoxazoles sustituidos | |
| ITUA20161288A1 (it) | Composizione per favorire la risalita degli spermatozoi nel canale cervico-vaginale umano. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |